SciSparc and Clearmind Collaboration Strengthens IP Portfolio with Patent Application in the U.S. for Treatment of Depression
April 21, 2023
Change to classification of psilocybin and MDMA to enable prescribing by authorised psychiatrists
February 3, 2023
Irwin Naturals Leverages Household Brand Status in Effort to be World’s Largest Chain of Psychedelic Mental Health Clinics
November 30, 2022
harmAla Submits Pre-IND Dossier for Novel MDMA Analog to FDA
November 2, 2022
Mydecine Files Full Patent Application Covering MYCO-006 Family of Novel Short-Acting MDMA Analogs
Biotechnology July 19, 2022
PharmAla Biotech Registers Trademark for MDMA
June 24, 2022
- 1
- 2